INN:

Class:

CD38 MAb

Adapted from Van de Donk N.W.C. et al. Monoclonal antibodies targeting CD38 in haematological malignancies and beyond. Immunol Rev. 2016 Mar; 270(1): 95-112. doi: 10.1111/imr.12389.

All content on this site is intended for healthcare professionals only. If you are a patient or carer, please visit the Lymphoma Coalition.